Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFN-α1b foraminal injection for postherpetic neuralgia
ChiCTR2400089962Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Sep 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of recombinant human interferon alpha-1b in postherpetic neuralgia (PHN) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Visual analogue scale and Pain relief rate. Started Sep 2024; status: recruiting.
02
Drugs
recombinant human interferon alpha-1b
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2400089962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089962.